Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Staar Surgical (STAA)
NASDAQ:STAA
STAA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$13.50 - $52.68
Previous CloseN/A
Volume326.32K
Average Volume (3M)1.08M
Market Cap
$819.46M
Enterprise Value$1.66B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)55.8
Beta0.95
Next Earnings
Apr 30, 2025EPS Estimate
-0.57Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.41
Shares Outstanding49,275,875
10 Day Avg. Volume1,864,501
30 Day Avg. Volume1,081,803
Standard Deviation0.18
R-Squared0.03
Alpha0.00236
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.40
Price to Cash Flow (P/CF)53.70
P/FCF Ratio0.00
Enterprise Value/Market Cap2.02
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit6.55
Enterprise Value/Ebitda52.41
Forecast
1Y Price Target
$18.67Price Target Upside5.06% Upside
Rating ConsensusHold
Number of Analyst Covering9
---
Bulls Say, Bears Say
Bulls Say
Financial StabilityThe company has $230M in cash and equivalents with no debt, which will allow it to weather macroeconomic headwinds.
Growth PotentialInvestors willing to weather the storm will likely have the opportunity to own a high quality, PMA-product company that can return to growth in the future.
US Market GrowthThe company expects its US business to grow 15% Y/Y and sequentially in Q1.
Bears Say
China Market UncertaintyThere is a wide range in the China revenue guide, showing a continued lack of visibility into the market, which makes it difficult to value the stock.
Inventory And Sales PressureSignificant inventory in the channel and no clear drivers to growth are expected to continue to pressure shares for the foreseeable future.
Revenue ChallengesSTAAR reported a significant Q4 miss, with revenue of $49.0M (-35.8% Y/Y), short CGe of $74.0M and consensus of $77.2M.
---
Ownership Overview
44.52% Insiders
19.04% Mutual Funds
0.11% Other Institutional Investors
7.27% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
STAA FAQ
What was Staar Surgical’s price range in the past 12 months?
Staar Surgical lowest stock price was $13.50 and its highest was $52.68 in the past 12 months.
What is Staar Surgical’s market cap?
Staar Surgical’s market cap is $819.46M.
When is Staar Surgical’s upcoming earnings report date?
Staar Surgical’s upcoming earnings report date is Apr 30, 2025 which is in 68 days.
How were Staar Surgical’s earnings last quarter?
Staar Surgical released its earnings results on Feb 11, 2025. The company reported -$0.514 earnings per share for the quarter, missing the consensus estimate of -$0.027 by -$0.487.
Is Staar Surgical overvalued?
According to Wall Street analysts Staar Surgical’s price is currently Undervalued.
Does Staar Surgical pay dividends?
Staar Surgical does not currently pay dividends.
What is Staar Surgical’s EPS estimate?
Staar Surgical’s EPS estimate is -0.57.
How many shares outstanding does Staar Surgical have?
Staar Surgical has 49,275,875 shares outstanding.
What happened to Staar Surgical’s price movement after its last earnings report?
Staar Surgical reported an EPS of -$0.514 in its last earnings report, missing expectations of -$0.027. Following the earnings report the stock price went down -24.68%.
Which hedge fund is a major shareholder of Staar Surgical?
Currently, no hedge funds are holding shares in STAA
---
Staar Surgical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$18.67 (5.06% Upside)
$18.67 (5.06% Upside)
Blogger Sentiment
Bullish
STAA Sentiment 80%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 45.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $8.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.9%
Last 30 Days ▲ 2.4%
Last 30 Days ▲ 2.4%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-42.39%
12-Months-Change
Fundamentals
Return on Equity
-5.16%
Trailing 12-Months
Asset Growth
4.26%
Trailing 12-Months
Company Description
Staar Surgical
STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It specializes in refractive and cataract solutions. Its products include intraocular lens and implantable collamer lens. The company was founded in 1982 and is headquartered in Lake Forest, CA.
---
STAA Company Deck
---
STAA Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Negative
STAAR Surgical faced significant challenges in China, which overshadowed strong performance in other regions. While the company continues to grow outside of China and gain market share in the U.S., the decline in China sales and the unrecognized revenue due to extended payment terms have negatively impacted overall results. The company remains optimistic about future growth and recovery, particularly in China, but the current challenges have led to a cautious outlook for fiscal 2025.Read More>---
STAA Stock 12 Month Forecast
Average Price Target
$18.67
▲(5.06% Upside)
Technical Analysis
Baxter International
―
Boston Scientific
―
Edwards Lifesciences
―
ICU Medical
―
Zimmer Biomet Holdings
―
Best Analysts Covering STAA
1 Year
1 Year Success Rate
1/10 ratings generated profit
1 Year Average Return
-35.48%
reiterated a buy rating 10 days ago
Copying Thomas Stephan's trades and holding each position for 1 Year would result in 10.00% of your transactions generating a profit, with an average return of -35.48% per trade.
---